Subsequently, we compared, at the molecular levels, mammary tumors induced by mutant AKT1E17K with those promoted by other oncogenes (i.e., p53, BRCA1, PIK3CA, Myc, Neu). The gene discussed is MYC; the disease is breast cancer.